Chronic GVHD and recipient genotype
| Genotype . | Chronic GVHD . | ||
|---|---|---|---|
| None . | Present . | Percent . | |
| RIFNγIntron1 genotype | |||
| RIFNγIntron1-3/3 | 13 | 6 | 31.6 |
| RIFNγIntron1-2/3 | 15 | 13 | 46.4 |
| RIFNγIntron1-2/2 | 8 | 8 | 50.0 |
| RIFNγIntron1-other | 6 | 3 | 33.3 |
| RIL-6−174genotype | |||
| RIL-6−174GG | 8 | 15 | 65.2 |
| RIL-6−174GC | 24 | 12 | 33.3 |
| RIL-6−174CC | 10 | 3 | 23.1 |
| Genotype . | Chronic GVHD . | ||
|---|---|---|---|
| None . | Present . | Percent . | |
| RIFNγIntron1 genotype | |||
| RIFNγIntron1-3/3 | 13 | 6 | 31.6 |
| RIFNγIntron1-2/3 | 15 | 13 | 46.4 |
| RIFNγIntron1-2/2 | 8 | 8 | 50.0 |
| RIFNγIntron1-other | 6 | 3 | 33.3 |
| RIL-6−174genotype | |||
| RIL-6−174GG | 8 | 15 | 65.2 |
| RIL-6−174GC | 24 | 12 | 33.3 |
| RIL-6−174CC | 10 | 3 | 23.1 |
The number of recipients possessing each cytokine genotype is shown with occurrence of cGVHD and the percentage of cGVHD.
R indicates recipient.